|
[1]
|
Chen, S.H. (2015) Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance. Pediatrics & Neonatology, 56, 287.
https://doi.org/10.1016/j.pedneo.2014.10.006
|
|
[2]
|
Hegyi, B., Komaromi, I., Nanasi, P.P., et al. (2013) Selectivity Problems with Drugs Acting on Cardiac Na(+) and Ca(2)(+) Channels. Current Medicinal Chemistry, 20, 2552-2571.
https://doi.org/10.2174/09298673113209990123
|
|
[3]
|
Etxabe, A., Lara-Castillo, M.C., Cornet-Masana, J.M., et al. (2017) Inhibition of Serotonin Receptor Type 1 in Acute Myeloid Leukemia Impairs Leukemia Stem Cell Functionality: A Promising Novel Therapeutic Target. Leukemia.
https://doi.org/10.1038/leu.2017.52
|
|
[4]
|
Guo, J., Russell, E.G., Darcy, R., et al. (2017) Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukemia: Physicochemical Characteristics, in Vitro Mechanistic Studies, and ex Vivo Patient Derived Therapeutic Efficacy. Molecular Pharmacology, 14, 940-952.
https://doi.org/10.1021/acs.molpharmaceut.6b01150
|
|
[5]
|
Zhu, G. (2013) Novel Treatment of Acute Promyelocytic Leukemia: As(2)O(3), Retinoic Acid and Retinoid Pharmacology. Current Pharmaceutical Biotechnology, 14, 849-858.
https://doi.org/10.2174/1389201015666140113095812
|
|
[6]
|
Mi, J.Q., Li, J.M., Shen, Z.X., et al. (2012) How to Manage Acute Promyelocytic Leukemia. Leukemia, 26, 1743-1751.
https://doi.org/10.1038/leu.2012.57
|
|
[7]
|
Abla, O. and Ribeiro, R.C. (2014) How I Treat Children and Adolescents with Acute Promyelocytic Leukaemia. British Journal of Haematology, 164, 24-38.
https://doi.org/10.1111/bjh.12584
|
|
[8]
|
Fredly, H., Ersvaer, E., Kittang, A.O., et al. (2013) The Combination of Valproic Acid, All-Trans Retinoic Acid and Low-Dose Cytarabine as Disease-Stabilizing Treatment in Acute Myeloid Leukemia. Clinical Epigenetics, 5, 13.
https://doi.org/10.1186/1868-7083-5-13
|
|
[9]
|
Lo-Coco, F. and Hasan, S.K. (2014) Understanding the Molecular Pathogenesis of Acute Promyelocytic Leukemia. Best Practice & Research Clinical Haematology, 27, 3-9.
https://doi.org/10.1016/j.beha.2014.04.006
|
|
[10]
|
Yanada, M., Tsuzuki, M., Fujita, H., et al. (2013) Phase 2 Study of Arsenic Trioxide Followed by Autologous Hematopoietic Cell Transplantation for Relapsed Acute Promyelocytic Leukemia. Blood, 121, 3095-3102.
https://doi.org/10.1182/blood-2012-11-466862
|
|
[11]
|
Rehman, K. and Naranmandura, H. (2013) Double-Edged Effects of Arsenic Compounds: Anticancer and Carcinogenic Effects. Current Drug Metabolism, 14, 1029-1041.
|
|
[12]
|
Wilcox, D.E. (2013) Arsenic. Can This Toxic Metalloid Sustain Life? Metal Ions in Life Sciences, 13, 475-498.
https://doi.org/10.1007/978-94-007-7500-8_15
|
|
[13]
|
Jeong, Y.M., Oh, W.K., Tran, T.L., et al. (2013) Aglycone of Rh4 Inhibits Melanin Synthesis in B16 Melanoma Cells: Possible Involvement of the Protein Kinase a Pathway. Bioscience, Biotechnology, and Biochemistry, 77, 119-125.
https://doi.org/10.1271/bbb.120602
|
|
[14]
|
Liu, Y., Xu, Y., Ji, W., et al. (2014) Anti-Tumor Activities of Matrine and Oxymatrine: Literature Review. Tumor Biology, 35, 5111-5119.
https://doi.org/10.1007/s13277-014-1680-z
|
|
[15]
|
Fan, J.M., Liu, Z.H., Li, J., et al. (2013) Effect of Ginseng Polysaccharide-Induced Wnt/Beta-Catenin Signal Transduction Pathway on Apoptosis of Human Nasopharyngeal Cancer Cells CNE-2. Zhongguo Zhong Yao Za Zhi, 38, 3332-3327.
|
|
[16]
|
Zhang, S., Zhang, Y., Zhuang, Y., et al. (2012) Matrine Induces Apoptosis in Human Acute Myeloid Leukemia Cells via the Mitochondrial Pathway and Akt Inactivation. PLoS One, 7, Article ID: e46853.
https://doi.org/10.1371/journal.pone.0046853
|
|
[17]
|
Wu, D., Shao, K., Sun, J., et al. (2014) Matrine Cooperates with All-Trans Retinoic Acid on Differentiation Induction of All-Trans Retinoic Acid-Resistant Acute Promyelocytic Leukemia Cells (NB4-LR1): Possible Mechanisms. Planta Medica, 80, 399-408.
https://doi.org/10.1055/s-0034-1368183
|
|
[18]
|
Wild, J., Schmiedel, B.J., Maurer, A., et al. (2015) Neutralization of NK Cell-Derived B Cell Activating Factor by Belimumab Restores Sensitivity of Chronic Lymphoid Leukemia Cells to Direct and Rituximab-Induced NK Lysis. Leukemia, 29, 1676.
https://doi.org/10.1038/leu.2015.50
|
|
[19]
|
Jain, P., Lee, H.J., Qiao, W., et al. (2014) FCR and Bevacizumab Treatment in Patients with Relapsed Chronic Lymphocytic Leukemia. Cancer, 120, 3494-3501.
https://doi.org/10.1002/cncr.28910
|
|
[20]
|
Tarlock, K., Chang, B., Cooper, T., et al. (2015) Sorafenib Treatment Following Hematopoietic Stem Cell Transplant in Pediatric FLT3/ITD Acute Myeloid Leukemia. Pediatr Blood Cancer, 62, 1048.
https://doi.org/10.1002/pbc.25437
|
|
[21]
|
Bhatia, A., Kanish, B. and Chaudhary, P. (2015) Lichenoid Drug Eruption due to Imatinib Mesylate. International Journal of Applied and Basic Medical Research, 5, 68-69.
https://doi.org/10.4103/2229-516X.149253
|
|
[22]
|
Xiang, D., Shigdar, S., Qiao, G., et al. (2015) Nucleic Acid Aptamer-Guided Cancer Therapeutics and Diagnostics: The Next Generation of Cancer Medicine. Theranostics, 5, 23-42.
https://doi.org/10.7150/thno.10202
|
|
[23]
|
Kim, M. and Costello, J. (2017) DNA Methylation: An Epigenetic Mark of Cellular Memory. Experimental and Molecular Medicine, 49, Article ID: e322.
https://doi.org/10.1038/emm.2017.10
|
|
[24]
|
Amabile, G., Di, R.A., Müller, F., et al. (2015) Dissecting the Role of Aberrant DNA Methylation in Human Leukaemia. Nature Communications, 6, 7091.
https://doi.org/10.1038/ncomms8091
|
|
[25]
|
Momparler, R.L., Côté, S., Momparler, L.F., et al. (2017) Inhibition of DNA and Histone Methylation by 5-Aza-2'- Deoxycytidine (Decitabine) and 3-Deazaneplanocin-A on Antineoplastic Action and Gene Expression in Myeloid Leukemic Cells. Frontiers in Oncology, 7, 19.
https://doi.org/10.3389/fonc.2017.00019
|
|
[26]
|
Gatla, H.R., Zou, Y., Uddin, M.M., et al. (2017) Histone Deacetylase (HDAC) Inhibition Induces IκB Kinase (IKK)-Dependent Interleukin-8/CXCL8 Expression in Ovarian Cancer Cells. Journal of Biological Chemistry, 292, 5043-5054.
https://doi.org/10.1074/jbc.M116.771014
|
|
[27]
|
D'Amato, L., Dell'Aversana, C., Conte, M., et al. (2015) ARHGEF3 Controls HDACi-Induced Differentiation via RhoA-Dependent Pathways in Acute Myeloid Leukemias. Epigenetics, 10, 6-18.
https://doi.org/10.4161/15592294.2014.988035
|
|
[28]
|
Mummaneni, P. and Shord, S.S. (2014) Epigenetics and Oncology. Pharmacotherapy, 34, 495-505.
https://doi.org/10.1002/phar.1408
|
|
[29]
|
Li, C., Tao, Y., Li, C., et al. (2016) PU.1-Bim Axis Is Involved in Trichostatin A-Induced Apoptosis in Murine Pro-B Lymphoma FL5.12 Cells. Acta Biochimica et Biophysica Sinica (Shanghai), 48, 850-855.
https://doi.org/10.1093/abbs/gmw067
|
|
[30]
|
Zhang, X., Ni, Z., Duan, Z., et al. (2015) Overexpression of E2F MRNAs Asso-ciated with Gastric Cancer Progression Identified by the Transcription Factor and MiRNA Co-Regulatory Network Analysis. PLoS One, 10, Article ID: e0116979.
https://doi.org/10.1371/journal.pone.0116979
|
|
[31]
|
Brauer-Hartmann, D., Hartmann, J.U., Wurm, A.A., et al. (2015) PML/RARα-Regulated MiR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia. Cancer Research, 75, 3411-3424.
https://doi.org/10.1158/0008-5472.CAN-14-3521
|
|
[32]
|
McCulloch, D., Brown, C. and Iland, H. (2017) Retinoic Acid and Arsenic Trioxide in the Treatment of Acute Promyelocytic Leukemia: Current Perspectives. Oncotargets and Therapy, 10, 1585-1601.
https://doi.org/10.2147/OTT.S100513
|
|
[33]
|
Atashrazm, F., Lowenthal, R.M., Dickinson, J.L., et al. (2016) Fucoidan Enhances the Therapeutic Potential of Arsenic Trioxide and All-Trans Retinoic Acid in Acute Promyelocytic Leukemia, in Vitro and in Vivo. Oncotarget, 7, 46028- 46041.
|